Amneal Pharmaceuticals, Inc. Stock News

If you're interested in Amneal Pharmaceuticals, Inc. (NYSE:AMRX), then you might want to consider its beta (a measure...

Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Digital Realty Trust, Pilgrims Pride and Terraform Power, on Tuesday. HIGH

Image source: The Motley Fool. Amneal Pharmaceuticals, Inc. (NYSE: AMRX)Q1 2020 Earnings CallMay 11, 2020, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared

Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Amyris Inc, BioCryst Pharmaceuticals Inc, Cytokinetics Inc. Read Harry Boxer's latest article on Investing.com

Amneal Pharmaceuticals Inc. (NYSE:AMRX) Q1 2020 Earnings Conference Call May 11, 2020 08:30 AM ET Company Participants Tasos Konidaris - SVP and CFO Chirag Pate

Amneal (AMRX) delivered earnings and revenue surprises of 150.00% and 12.50%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Shares of Amneal Pharmaceuticals (NYSE:AMRX) moved higher by 13% in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share rose 42.86% year over year to $0.20, w

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the "Company") announced its results today for the first quarter ended March 31, 2020.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) announced its results today for the first quarter ended March 31, 2020. “We are proud of how

The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...

Amneal (AMRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

The epinephrine autoinjector market is poised to grow by 762.51 mn during 2020-2024, according to Technavio

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa

This week in patent filings, PTAB filings are back up, with four post grant reviews and 37 inter partes reviews, while there were 83 district court complaints; the district court numbers skew high bec

'Millions' of doses of Oxford University's vaccine could be available as early as September with human trials, consisting of 6,000 participants, set to begin in May, it has been reported